Methods for detection and confirmation of Hematide™/peginesatide in anti-doping samples

Forensic Science International

Volumn 213, Issue 1-3, 2011, Pages 15-19

  Leuenberger, Nicolas ^a   Saugy, Jérémy ^a   Mortensen, Richard B ^b   Schatz, Peter J ^b   Giraud, Sylvain ^a   Saugy, Martial ^a  

^a UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

^b AFFYMAX RESEARCH INSTITUTE   (United States)

Author keywords

Assay; Detection; Doping; Hematide (peginesatide); Implementation; Screening

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; PEGINESATIDE;

ARTICLE; ATHLETE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOPING; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIESIS; HUMAN; IMMUNOPRECIPITATION; LABORATORY TEST; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PURIFICATION; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEQUENCE HOMOLOGY; VOLUNTEER; WESTERN BLOTTING;

EID: 80655124644     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2011.07.012     Document Type: Article

References (15)

1. Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol. Rev. 1992, 72(2):449-489.
2. Jelkmann W. Molecular biology of erythropoietin. Intern. Med. 2004, 43(8):649-659.
3. Weiss G., Goodnough L.T. Anemia of chronic disease. N. Engl. J. Med. 2005, 352(10):1011-1023.
4. Macdougall I.C. Recent advances in erythropoietic agents in renal anemia. Semin. Nephrol. 2006, 26(4):313-318.
5. Fan Q., et al. Preclinical evaluation of Hematide: a novel erythropoiesis stimulating agent, for the treatment of anemia. Exp. Hematol. 2006, 34(10):1303-1311.
6. Woodburn K.W., et al. Hematide is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model. Exp. Hematol. 2007, 35(8):1201-1208.
7. Cooper C.E. The biochemistry of drugs and doping methods used to enhance aerobic sport performance. Essays Biochem. 2008, 44:63-83.
8. Borrione P., et al. Oxygen delivery enhancers: past, present, and future. J. Endocrinol. Invest. 2008, 31(2):185-192.
9. Kazlauskas R., Howe C., Trout G. Strategies for rhEPO detection in sport. Clin. J. Sport Med. 2002, 12(4):229-235.
10. Engvall E., Perlmann P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry 1971, 8(9):871-874.
11. Zweig M.H., Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 1993, 39(4):561-577.
12. Stead R.B., et al. Evaluation of the safety and pharmacodynamics of Hematide: a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers. Blood 2006, 108(6):1830-1834.
13. Lasne F. Double-blotting: a solution to the problem of nonspecific binding of secondary antibodies in immunoblotting procedures. Methods Mol. Biol. 2009, 536:213-219.
14. Reichel C., et al. SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control. Drug Test Anal. 2009, 1(1):43-50.
15. Benkimoun P. Police find range of drugs after trawling bins used by Tour de France cyclists. BMJ 2009, 339:pb4201.